SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001387131-23-003546
Filing Date
2023-03-17
Accepted
2023-03-17 08:08:25
Documents
4

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT admp-8k_031622.htm DEFA14A 33505
2 TRANSCRIPT OF CONFERENCE CALL ex99-1.htm EX-99.1 46627
3 TRANSCRIPT OF VIDEO PRESENTATION ex99-2.htm EX-99.2 19211
4 PRESS RELEASE ex99-3.htm EX-99.3 42984
  Complete submission text file 0001387131-23-003546.txt   143428
Mailing Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Filer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36242 | Film No.: 23740729
SIC: 2834 Pharmaceutical Preparations